• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GTx

GTx

GTx Inc GTXI

Last Price$0.77Day Change (%)-6.10%
Open Price$0.81Day Change ($)-0.05
Day Range0.76–0.8252-Week Range0.41–2.35

As of Wed 12/24/2014 01:00 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. How’s the Market Feeling These Days?

    GTx GTXI announced Thursday that the Data Safety Monitoring Board has given it the green light to proceed with Phase III trials for Acapodene. We're leaving our fair value estimate unchanged as we had anticipated a smooth interim review. In our opinion, Acapodene's potential exposure to generic ...

  2. GAIN Capital Announces Monthly Metrics for November 2014

    GAIN Capital Announces Monthly Metrics for November 2014

  3. Research and Markets: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

    Research and Markets: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

  4. America: The New Europe?

    GTx adds a European partner.

  5. When Flexibility Meets Opportunity in the European Commercial Real Estate Market

    We are raising GTx's fair value on recent positive Phase II trial results for Ostarine.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.